These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34981532)

  • 1. Synthesis, characterization and control of eight process-related and two genotoxic fingolimod impurities by a validated RP-UPLC method.
    Bellur Atici E; Yazar Y; Rıdvanoğlu N
    Biomed Chromatogr; 2022 Apr; 36(4):e5316. PubMed ID: 34981532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC.
    Rajana N; Devi DR; Kumar Reddy DN; Babu JM; Basavaiah K; Balakumaran K
    J Chromatogr Sci; 2020 Apr; 58(5):433-444. PubMed ID: 32134104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
    Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
    J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impurity assessment, development and validation of an RP-HPLC method for the determination of eleven potential impurities of eltrombopag precursor.
    Demirhan T; Guksu E; Yazar Y; Keskin E; Bellur Atici E; Özkan SA
    J Pharm Biomed Anal; 2024 Jun; 243():116085. PubMed ID: 38471254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
    A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
    J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of the process-related impurities in fasudil hydrochloride by hyphenated techniques using a quality by design approach.
    Song M; Chen YQ; Lu PB; Hang TJ
    J Sep Sci; 2014 Apr; 37(7):758-63. PubMed ID: 24470347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis.
    Ruggenthaler M; Grass J; Schuh W; Huber CG; Reischl RJ
    J Pharm Biomed Anal; 2017 Feb; 135():140-152. PubMed ID: 28024262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and Characterization of an Unknown Process-Related Impurity in Furosemide and Validation of a New HPLC Method.
    Xu A; Xue Y; Zeng Y; Li J; Zhou H; Wang Z; Chen Y; Chen H; Jin J; Zhuang T
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
    Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
    Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability profiling of anti-malarial drug piperaquine phosphate and impurities by HPLC-UV, TOF-MS, ESI-MS and NMR.
    Yan F; Liu J; Zeng X; Zhang Y; Hang T
    Malar J; 2014 Oct; 13():401. PubMed ID: 25311421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
    Prajapati KJ; Kothari CS
    Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential impurities of anxiolytic drug, clobazam: Identification, synthesis and characterization using HPLC, LC-ESI/MS
    Kumar N; Devineni SR; Dubey SK; Kumar P
    J Pharm Biomed Anal; 2017 Apr; 137():268-278. PubMed ID: 28183048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPLC separation, synthesis, isolation and characterization of process related and degradation impurities in larotaxel including method development and validation.
    Yao K; Wang H; Xie X; Li J; You R; Li Y; Zhang H
    J Pharm Biomed Anal; 2023 Sep; 233():115435. PubMed ID: 37196590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Analysis and Quantitative Determination of Clevidipine Butyrate Impurities Using an Advanced RP-HPLC Method.
    Zhou Y; Zhou F; Yan F; Yang F; Yao Y; Zou Q
    J Chromatogr Sci; 2016 Mar; 54(3):353-60. PubMed ID: 26489435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
    Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
    J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of unknown impurities in Coenzyme Q
    Deng Y; Chen X; Wang L; Peng X; Lin M
    J Pharm Biomed Anal; 2019 Oct; 175():112771. PubMed ID: 31330281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, synthesis and structural confirmation of process-related impurities in proparacaine hydrochloride.
    Yang Z; Zhao J; Feng Y; Lei Y; Liu D; Qin F; Zheng J; Wang S
    J Pharm Biomed Anal; 2020 Oct; 190():113497. PubMed ID: 32798917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
    Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB
    J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.